| Literature DB >> 19574209 |
Pilar Sánchez Henarejos1, Silverio Ros Martínez, Gema R Marín Zafra, José L Alonso Romero, Agustín Navarrete Montoya.
Abstract
Pegylated liposomal doxorubicin (PLD) is a drug whose use is increasingly common. It has been associated with a lower rate of haematologic and cardiac side effects than its nonencapsulated form. However, mucocutaneous toxicity is quite frequent and can be severe. Here we provide a case report of a patient who developed an intertrigolike eruption during treatment with PLD.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19574209 DOI： 10.1007/s12094-009-0390-2
Source DB: PubMed Journal: Clin Transl Oncol ISSN： 1699-048X Impact factor: 3.405